These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 19085632)

  • 1. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J; Chedraui P; Hidalgo L; Medina M
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.
    Duhig KE; Chandiramani M; Seed PT; Briley AL; Kenyon AP; Shennan AH
    BJOG; 2009 May; 116(6):799-803. PubMed ID: 19432568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions.
    Mateus J; Pereira L; Baxter J; Berghella V; Tolosa J
    Am J Perinatol; 2007 Jun; 24(6):381-5. PubMed ID: 17566945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM; Liu E; Allenby K
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of fetal fibronectin for predicting preterm birth.
    Swamy GK; Simhan HN; Gammill HS; Heine RP
    J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies.
    Fox NS; Rebarber A; Roman AS; Klauser CK; Peress D; Saltzman DH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2308-11. PubMed ID: 22563765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin.
    Riboni F; Vitulo A; Dell'avanzo M; Plebani M; Battagliarin G; Paternoster D
    Arch Gynecol Obstet; 2011 Dec; 284(6):1325-9. PubMed ID: 21274721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the fetal fibronectin test be used by remote dwelling pregnant women to predict the onset of labour at term and delay transfer for birth in regional settings?
    Rumbold A; Kruske S; Boyle J; Weckert R; Putland S; Giles L; Barclay L; Kildea S
    Rural Remote Health; 2013; 13(2):2126. PubMed ID: 23351083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage.
    Benson JE; Landy HJ; Ghidini A; Drassinower D; Poggi SH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2330-2. PubMed ID: 22694302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of digital cervical examination on the expression of fetal fibronectin.
    McKenna DS; Chung K; Iams JD
    J Reprod Med; 1999 Sep; 44(9):796-800. PubMed ID: 10509304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.
    Shennan A; Jones G; Hawken J; Crawshaw S; Judah J; Senior V; Marteau T; Chinn S; Poston L
    BJOG; 2005 Mar; 112(3):293-8. PubMed ID: 15713142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor.
    Singer E; Pilpel S; Bsat F; Plevyak M; Healy A; Markenson G
    Obstet Gynecol; 2007 May; 109(5):1083-7. PubMed ID: 17470586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I; Marek S; Hellmeyer L; Reitz D; Schmidt S
    Obstet Gynecol; 2005 Feb; 105(2):280-4. PubMed ID: 15684152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery.
    Kurtzman J; Chandiramani M; Briley A; Poston L; Das A; Shennan A
    Am J Obstet Gynecol; 2009 Mar; 200(3):263.e1-6. PubMed ID: 19254585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
    Roman AS; Koklanaris N; Paidas MJ; Mulholland J; Levitz M; Rebarber A
    Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.